NM
TSVT

Newtyn Management’s 2seventy bio TSVT Stock Holding History

Newtyn Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,534,836
Closed -$12.5M – 38
2025
Q1 		$12.5M Hold
2,534,836
– – 1.98% 16
2024
Q4 		$7.45M Sell
2,534,836
-5,164
-0.2% -$21.2K 1.3% 22
2024
Q3 		$12M Buy
2,540,000
+55,000
+2% +$248K 1.84% 19
2024
Q2 		$9.57M Buy
+2,485,000
New +$11.2M 1.8% 20
2023
Q4 		– Sell
-3,076,490
Closed -$12.1M – 52
2023
Q3 		$12.1M Buy
3,076,490
+2,338,746
+317% +$15.3M 2.98% 11
2023
Q2 		$7.47M Sell
737,744
-767,256
-51% -$8.12M 1.76% 16
2023
Q1 		$15.4M Buy
1,505,000
+622,866
+71% +$7.12M 3.02% 9
2022
Q4 		$8.27M Sell
882,134
-67,866
-7% -$957K 1.71% 22
2022
Q3 		$13.8M Sell
950,000
-396,796
-29% -$5.89M 3.03% 11
2022
Q2 		$17.8M Sell
1,346,796
-241,009
-15% -$3.28M 3.37% 11
2022
Q1 		$27.1M Buy
1,587,805
+1,122,511
+241% +$19M 6.49% 3
2021
Q4 		$11.9M Buy
+465,294
New +$14.5M 3.17% 15

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Newtyn Management's TSVT Position: Q2 2025 in Review

Newtyn Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 2,534,836 shares — an estimated $12.5M sold.

Newtyn Management first reported a position in TSVT in Q4 2021 and held it in 12 quarters. The position peaked at $27.1M in Q1 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Newtyn Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Newtyn Management sold 2,534,836 2seventy bio shares in Q2 2025, an estimated $12.5M.
  • Newtyn Management first reported a position in 2seventy bio in Q4 2021 and held it in 12 quarters.
  • Newtyn Management's 2seventy bio position peaked at $27.1M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Newtyn Management's 13F filing for Q2 2025, filed 14 Aug 2025.